BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 27114702)

  • 21. Andrographolide attenuates bupivacaine-induced cytotoxicity in SH-SY5Y cells through preserving Akt/mTOR activity.
    Zhang H; Wang W; Du Q
    Drug Des Devel Ther; 2019; 13():1659-1666. PubMed ID: 31190744
    [No Abstract]   [Full Text] [Related]  

  • 22. Active lipids of Ganoderma lucidum spores-induced apoptosis in human leukemia THP-1 cells via MAPK and PI3K pathways.
    Wang JH; Zhou YJ; Zhang M; Kan L; He P
    J Ethnopharmacol; 2012 Jan; 139(2):582-9. PubMed ID: 22172327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the PI3K pathway sensitizes fludarabine-induced apoptosis in human leukemic cells through an inactivation of MAPK-dependent pathway.
    Yu C; Mao X; Li WX
    Biochem Biophys Res Commun; 2005 Jun; 331(2):391-7. PubMed ID: 15850772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling.
    Wang Z; Jiang C; Ganther H; Lü J
    Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
    Alameen AA; Simioni C; Martelli AM; Zauli G; Ultimo S; McCubrey JA; Gonelli A; Marisi G; Ulivi P; Capitani S; Neri LM
    Oncotarget; 2016 Aug; 7(34):55690-55703. PubMed ID: 27494886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.
    Zhang L; Yang X; Li X; Li C; Zhao L; Zhou Y; Hou H
    Int J Mol Med; 2015 Oct; 36(4):957-66. PubMed ID: 26310353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.
    Cani A; Simioni C; Martelli AM; Zauli G; Tabellini G; Ultimo S; McCubrey JA; Capitani S; Neri LM
    Oncotarget; 2015 Mar; 6(9):6597-610. PubMed ID: 25788264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of NF-kB and COX-2 by andrographolide regulates the progression of cervical cancer by promoting PTEN expression and suppressing PI3K/AKT signalling pathway.
    Pasha A; Kumar K; Heena SK; Arnold Emerson I; Pawar SC
    Sci Rep; 2024 May; 14(1):12020. PubMed ID: 38797813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timosaponin A‑III induces autophagy of T‑cell acute lymphoblastic leukemia Jurkat cells via inhibition of the PI3K/Akt/mTOR pathway.
    Wang H; Dong R; Fan WW; Zheng XC; Li AM; Wang WD
    Oncol Rep; 2019 May; 41(5):2937-2944. PubMed ID: 30896824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
    Lonetti A; Cappellini A; Bertaina A; Locatelli F; Pession A; Buontempo F; Evangelisti C; Evangelisti C; Orsini E; Zambonin L; Neri LM; Martelli AM; Chiarini F
    J Hematol Oncol; 2016 Oct; 9(1):114. PubMed ID: 27776559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Andrographolide Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer Cells by Interfering with NF- κ B and PI3K/AKT Signaling In Vitro and In Vivo.
    Xuan L; Hu JH; Bi R; Liu SQ; Wang CX
    Chin J Integr Med; 2022 Apr; 28(4):349-356. PubMed ID: 35048242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PI3-K/Akt-dependent activation of cAMP-response element-binding (CREB) protein in Jurkat T leukemia cells treated with TRAIL.
    Caravatta L; Sancilio S; di Giacomo V; Rana R; Cataldi A; Di Pietro R
    J Cell Physiol; 2008 Jan; 214(1):192-200. PubMed ID: 17579344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical roles of cellular glutathione homeostasis and jnk activation in andrographolide-mediated apoptotic cell death in human hepatoma cells.
    Ji L; Shen K; Jiang P; Morahan G; Wang Z
    Mol Carcinog; 2011 Aug; 50(8):580-91. PubMed ID: 21319226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of hedgehog signaling by GANT58 induces apoptosis and shows synergistic antitumor activity with AKT inhibitor in acute T cell leukemia cells.
    Hou X; Chen X; Zhang P; Fan Y; Ma A; Pang T; Song Z; Jin Y; Hao W; Liu F; Wang W; Wang Y
    Biochimie; 2014 Jun; 101():50-9. PubMed ID: 24394624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
    Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Andrographolide inhibits proliferation and induces apoptosis of nasopharyngeal carcinoma cell line C666-1 through LKB1-AMPK-dependent signaling pathways.
    Wu B; Chen X; Zhou Y; Hu P; Wu D; Zheng G; Cai Y
    Pharmazie; 2018 Oct; 73(10):594-597. PubMed ID: 30223924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy.
    Ksionda O; Mues M; Wandler AM; Donker L; Tenhagen M; Jun J; Ducker GS; Matlawska-Wasowska K; Shannon K; Shokat KM; Roose JP
    PLoS One; 2018; 13(5):e0193849. PubMed ID: 29799846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Andrographolide reduces proliferation and migration of lens epithelial cells by modulating PI3K/Akt pathway.
    Kayastha F; Madhu H; Vasavada A; Johar K
    Exp Eye Res; 2014 Nov; 128():23-6. PubMed ID: 25220506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade.
    Chao TH; Tseng SY; Li YH; Liu PY; Cho CL; Shi GY; Wu HL; Chen JH
    Clin Sci (Lond); 2012 Aug; 123(3):147-59. PubMed ID: 22339730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.